January 2027
CFP closes 2 Jan
Global Summit on Immunotherapy & Cancer Breakthroughs
GSICB 2027
Global Summit on Immunotherapy & Cancer Breakthroughs is a 2-day event in Boston, USA on 29–30 January 2027, organized by World Research Association for Education and Science. Abstracts are due by 2 January 2027. Its call for papers covers Advanced Cancer Immunotherapy, • Next Generation Immunotherapy and • Precision Cancer Immunotherapy, among other areas. World Research Association for Education and Science has 389 other upcoming conferences listed here.
Important dates
-
Abstract / full paper deadline
In 48 days
-
Conference
Boston, Massachusetts, USA
All deadlines are as published by the organizer. Check the official website for the time zone.
About this conference
Global Summit on Immunotherapy & Cancer Breakthroughs GSICB, organized by World Research Association for Education and Science, is a leading international conference that connects researchers, engineers, healthcare professionals, academicians, scientists, industry experts, and professionals from around the world. The conference provides a global platform to share groundbreaking research, discuss emerging developments, showcase innovative ideas, and build meaningful professional collaborations. By bringing together diverse academic and professional communities, Global Summit on Immunotherapy & Cancer Breakthroughs GSICB aims to promote knowledge exchange, interdisciplinary collaboration, innovation, and the advancement of research on a global scale.
Topics and scope
- Advanced Cancer Immunotherapy
- • Next Generation Immunotherapy
- • Precision Cancer Immunotherapy
- • Immune Checkpoint Inhibitors
- • PD1 PDL1 Targeting
- • CTLA4 Targeted Therapy
- • Nextgen Checkpoint Strategies
- • CAR T Cell Therapy
- • Next Generation CAR T
- • In Vivo CAR T
- • CAR NK Cell Therapy
- • Engineered T Cell Therapies
- • TCR T Cell Therapy
- • Adoptive Cell Therapies
- • Tumor Infiltrating Lymphocytes
- • Bispecific Antibody Therapies
- • Multispecific Immune Engagers
- • T Cell Engager Platforms
- • Cancer Vaccine Innovations
- • Personalized Cancer Vaccines
- • Neoantigen Vaccine Development
- • mRNA Cancer Vaccines
- • In Situ Cancer Vaccines
- • Oncolytic Virus Immunotherapy
- • Cancer Immunotherapy Combinations
- • Immunotherapy Drug Combinations
- • Targeted Immunotherapy Strategies
- • Tumor Microenvironment Modulation
- • Immune Suppressive Microenvironment
- • Tumor Immune Escape
- • Immunotherapy Resistance Mechanisms
- • Overcoming Immunotherapy Resistance
- • Biomarkers For Immunotherapy
- • Predictive Immune Biomarkers
- • Precision Immuno Oncology
- • AI Driven Immunotherapy
- • Computational Cancer Immunology
- • Genomic Immunotherapy Biomarkers
- • Personalized Immune Treatments
- • Immunotherapy For Solid Tumors
- • Immunotherapy For Blood Cancers
- • Lung Cancer Immunotherapy
- • Breast Cancer Immunotherapy
- • Melanoma Immunotherapy Advances
- • Colorectal Cancer Immunotherapy
- • Brain Cancer Immunotherapy
- • Immunotherapy Toxicity Management
- • Cytokine Release Syndrome
- • Immune Related Adverse Events
- • Clinical Immunotherapy Translation
Call for papers
Abstracts are due by 2 January 2027. Submission details are on the official website.
Where this information comes from
- Source
- Submitted by the organizer
- Listed on
- 19 October 2026
- Verification
- Reviewed by an editor before publishing
- Reference
- FCA2906196
Questions about GSICB 2027
When and where is GSICB 2027?
29–30 January 2027 in Boston, Massachusetts, USA.
Can I attend online?
This listing does not confirm an online option. Check the official website.
What is the submission deadline?
Abstracts are due by 2 January 2027.
How do I register?
Registration and fees are handled by the organizer on the official website.
Verify that you represent this event.
Tell us what needs to be reviewed.